175 related articles for article (PubMed ID: 10930997)
1. In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.
Aldinucci D; Poletto D; Zagonel V; Rupolo M; Degan M; Nanni P; Gattei V; Pinto A
Br J Haematol; 2000 Jul; 110(1):188-96. PubMed ID: 10930997
[TBL] [Abstract][Full Text] [Related]
2. 2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma.
Grigg AP
Leuk Lymphoma; 2001 Aug; 42(4):797-9. PubMed ID: 11697510
[TBL] [Abstract][Full Text] [Related]
3. Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.
Corazzelli G; Capobianco G; Russo F; Frigeri F; Aldinucci D; Pinto A
Haematologica; 2005 Mar; 90(3):ECR14. PubMed ID: 15753055
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Suarez F; Wlodarska I; Rigal-Huguet F; Mempel M; Martin-Garcia N; Farcet JP; Delsol G; Gaulard P
Am J Surg Pathol; 2000 Jul; 24(7):1027-32. PubMed ID: 10895827
[TBL] [Abstract][Full Text] [Related]
5. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.
Macon WR; Levy NB; Kurtin PJ; Salhany KE; Elkhalifa MY; Casey TT; Craig FE; Vnencak-Jones CL; Gulley ML; Park JP; Cousar JB
Am J Surg Pathol; 2001 Mar; 25(3):285-96. PubMed ID: 11224598
[TBL] [Abstract][Full Text] [Related]
6. CD26 expression correlates with a reduced sensitivity to 2'-deoxycoformycin-induced growth inhibition and apoptosis in T-cell leukemia/lymphomas.
Aldinucci D; Poletto D; Lorenzon D; Nanni P; Degan M; Olivo K; Rapanà B; Pinto A; Gattei V
Clin Cancer Res; 2004 Jan; 10(2):508-20. PubMed ID: 14760072
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
8. Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.
Iannitto E; Barbera V; Quintini G; Cirrincione S; Leone M
Br J Haematol; 2002 Jun; 117(4):995-6. PubMed ID: 12060145
[No Abstract] [Full Text] [Related]
9. [A case of hepatosplenic gammadelta T cell lymphoma].
Wang FX; Zhang XJ; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):505-8. PubMed ID: 15972153
[TBL] [Abstract][Full Text] [Related]
10. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy.
Bennett M; Matutes E; Gaulard P
Am J Hematol; 2010 Sep; 85(9):727-9. PubMed ID: 20652973
[TBL] [Abstract][Full Text] [Related]
12. Hepatosplenic and other gammadelta T-cell lymphomas.
Vega F; Medeiros LJ; Gaulard P
Am J Clin Pathol; 2007 Jun; 127(6):869-80. PubMed ID: 17509984
[TBL] [Abstract][Full Text] [Related]
13. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
Duan DS; Smith W; Sadée W; Cowan MJ
Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.
Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H
J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893
[TBL] [Abstract][Full Text] [Related]
15. Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.
Steurer M; Stauder R; Grünewald K; Gunsilius E; Duba HC; Gastl G; Dirnhofer S
Hum Pathol; 2002 Feb; 33(2):253-8. PubMed ID: 11957154
[TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic T-cell lymphoma.
Franco V; Florena AM
Br J Haematol; 2001 Jul; 114(1):3. PubMed ID: 11472337
[No Abstract] [Full Text] [Related]
17. Challenges and new prospects in hepatosplenic γδ T-cell lymphoma.
Calvaruso M; Gulino A; Buffa S; Guarnotta C; Franco G; Cacciatore M; Bonura MG; Franco V; Florena AM
Leuk Lymphoma; 2014 Nov; 55(11):2457-65. PubMed ID: 24506469
[TBL] [Abstract][Full Text] [Related]
18. Rare variety of T-cell lymphoma.
Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
[TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration.
Tamaska J; Adam E; Kozma A; Gopcsa L; Andrikovics H; Tordai A; Halm G; Bereczki L; Bagdi E; Krenacs L
Virchows Arch; 2006 Oct; 449(4):479-83. PubMed ID: 16941150
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenic γδ T-cell lymphoma: an overview.
Visnyei K; Grossbard ML; Shapira I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):360-9. PubMed ID: 23876844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
